The three panels on the left side show HR+/HER2+ breast cancer patients, the three panels in the middle left show HR+/HER2− breast cancer patients, the three panels in the middle right display HR−/HER2+ breast cancer patients, and the three panels on the right side show HR−/HER2− breast cancer patients in three different stages. This evidence concerns the gene ERBB2 and breast cancer.